Humacyte, Inc. Research And Development Expense

• Humacyte, Inc. showed a decrease of -21.8% in Research And Development Expense from 2024 to 2025.
• This data is from Humacyte, Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
• XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 6 years of available data (2020 to 2025), Humacyte, Inc.'s Research And Development Expense has grown by 28.2%.
• Historical annual values: Fiscal year 2025: $69.30 million | Fiscal year 2024: $88.60 million | Fiscal year 2023: $76.55 million | Fiscal year 2022: $63.26 million | Fiscal year 2021: $61.34 million | Fiscal year 2020: $54.08 million.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026